or Try an Advanced Search...

    Technical Analysis for ACIU - AC Immune SA

    Grade Last Price % Change Price Change
    B 3.98 -0.25% -0.01
    ACIU closed down 0.25 percent on Monday, July 1, 2024, on 16 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical ACIU trend table...
    Date Alert Name Type % Chg
    Gapped Down Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Oversold Stochastic Weakness -0.25%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.25%
    Spinning Top Other 0.25%
    Narrow Range Bar Range Contraction 0.25%
    Oversold Stochastic Weakness 0.25%
    Hammer Candlestick Bullish 0.25%
    Stochastic Buy Signal Bullish 0.25%
    Lizard Bullish Bullish Day Trade Setup 0.25%
    Older End-of-Day Signals for ACIU ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 7 hours ago
    Down 3% about 7 hours ago
    Fell Below Previous Day's Low about 7 hours ago
    Down 2 % about 7 hours ago
    Down 1% about 7 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ACIU Chart by TradingView
    Basic chart:

    Profile

    AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimer’s and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinson's, and focuses on producing therapeutic and diagnostic product candidates, using SupraAntigen and Morphomer technology platforms. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta and Morphomer alpha-syn, among others.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biology Organ Systems Imaging Alzheimer's Disease Parkinson's Disease Neurological Disorders Neurodegenerative Diseases Dementia Psychiatric Diagnosis Glaucoma Degenerative Disease Neurodegeneration Imaging Agent Amyloid Beta Company's Pipeline

    Is ACIU a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 5 bullish, 0 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 15 Here's Why Shareholders May Want To Be Cautious With Increasing AC Immune SA's (NASDAQ:ACIU) CEO Pay Packet
    Jun 14 RH Posts Mixed Q1 Results, Joins MSC Industrial Direct And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Jun 13 The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
    Jun 10 AC Immune SA (NASDAQ:ACIU): Are Analysts Optimistic?
    May 28 AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
    May 21 Individual investors own 24% of AC Immune SA (NASDAQ:ACIU) shares but private equity firms control 30% of the company
    May 13 Sector Update: Health Care Stocks Mixed Late Afternoon
    May 13 Top Midday Gainers
    May 13 Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
    May 13 Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy
    See more ACIU news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.14
    52 Week Low 2.2
    Average Volume 1,016,282
    200-Day Moving Average 3.35
    50-Day Moving Average 3.50
    20-Day Moving Average 4.33
    10-Day Moving Average 4.04
    Average True Range 0.28
    RSI (14) 49.49
    ADX 25.01
    +DI 26.12
    -DI 22.05
    Chandelier Exit (Long, 3 ATRs) 4.15
    Chandelier Exit (Short, 3 ATRs) 4.55
    Upper Bollinger Bands 4.98
    Lower Bollinger Band 3.68
    Percent B (%b) 0.23
    BandWidth 29.99
    MACD Line 0.08
    MACD Signal Line 0.18
    MACD Histogram -0.1
    Fundamentals Value
    Market Cap 393.23 Million
    Num Shares 98.8 Million
    EPS -0.94
    Price-to-Earnings (P/E) Ratio -4.23
    Price-to-Sales 284765.75
    Price-to-Book 1.86
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.24
    Resistance 3 (R3) 4.23 4.13 4.19
    Resistance 2 (R2) 4.13 4.07 4.14 4.18
    Resistance 1 (R1) 4.06 4.03 4.10 4.07 4.16
    Pivot Point 3.96 3.96 3.98 3.97 3.96
    Support 1 (S1) 3.89 3.90 3.93 3.89 3.80
    Support 2 (S2) 3.79 3.86 3.80 3.78
    Support 3 (S3) 3.72 3.79 3.77
    Support 4 (S4) 3.72